| Literature DB >> 35705045 |
Bastien Dolfi1, Alexandre Gallerand1, Maria M Firulyova2, Yingzheng Xu3, Johanna Merlin4, Adélie Dumont4, Alexia Castiglione4, Nathalie Vaillant4, Sandrine Quemener5, Heidi Gerke6, Marion I Stunault4, Patricia R Schrank3, Seung-Hyeon Kim7, Alisha Zhu3, Jie Ding7, Jerome Gilleron4, Virginie Magnone8, Pascal Barbry8, David Dombrowicz5, Christophe Duranton9, Abdelilah Wakkach9, Claudine Blin-Wakkach9, Burkhard Becher10, Sophie Pagnotta11, Rafael J Argüello12, Pia Rantakari6, Svetoslav Chakarov13, Florent Ginhoux14, Konstantin Zaitsev2, Ki-Wook Kim7, Laurent Yvan-Charvet4, Rodolphe R Guinamard1, Jesse W Williams15, Stoyan Ivanov16.
Abstract
Despite the ubiquitous function of macrophages across the body, the diversity, origin, and function of adrenal gland macrophages remain largely unknown. We define the heterogeneity of adrenal gland immune cells using single-cell RNA sequencing and use genetic models to explore the developmental mechanisms yielding macrophage diversity. We define populations of monocyte-derived and embryonically seeded adrenal gland macrophages and identify a female-specific subset with low major histocompatibility complex (MHC) class II expression. In adulthood, monocyte recruitment dominates adrenal gland macrophage maintenance in female mice. Adrenal gland macrophage sub-tissular distribution follows a sex-dimorphic pattern, with MHC class IIlow macrophages located at the cortico-medullary junction. Macrophage sex dimorphism depends on the presence of the cortical X-zone. Adrenal gland macrophage depletion results in altered tissue homeostasis, modulated lipid metabolism, and decreased local aldosterone production during stress exposure. Overall, these data reveal the heterogeneity of adrenal gland macrophages and point toward sex-restricted distribution and functions of these cells.Entities:
Keywords: CP: Immunology; adrenal gland; macrophage; monocyte; sex dimorphism
Mesh:
Substances:
Year: 2022 PMID: 35705045 PMCID: PMC9210345 DOI: 10.1016/j.celrep.2022.110949
Source DB: PubMed Journal: Cell Rep Impact factor: 9.995
Figure 1Macrophages are the main adrenal gland immune subset and possess a sex-specific localization
(A) Quantification of macrophages, monocytes, and DCs in the adrenal glands of 7-week-old male and female wild-type mice. Macrophages: ♂ n = 16 and ♀ n = 15. Monocytes: ♂ n = 11 and ♀ n = 10. DCs: ♂ and ♀ n = 15. Data pooled from 2 (monocytes) or 3 (macrophages and DCs) independent experiments.
(B) Histograms representing CD11b, CD11c, and F4/80 expression on male and female AGMs. Data are representative of at least 4 independent experiments.
(C and D) Representative images of R26TdTomato expression in adrenal glands from 10- to 12-week-old female Lyz2cre (C) and CD115creERT2 (D) mice 24 h after TAM administration. Scale bars: 100 μm. Data are from one experiment.
(E) Flow-cytometry analysis of CX3CR1GFP expression in male and female AGMs. ♂ n = 12 and ♀ n = 12. Data are pooled from 3 independent experiments.
(F) Microscopy analysis of CX3CR1+ cells localization in 8-week-old male and female (nulliparous) CX3CR1GFP/+ mice. Scale bar: 100 μm. Data are representative of at least 4 independent experiments. Two-tailed Mann-Whitney tests were used for statistical analysis.
See also Figure S1 and Table S1.
Figure 2scRNA-seq analysis reveals adrenal gland leukocyte diversity and monocyte contribution to the macrophage pool
(A) scRNA-seq analysis of adrenal gland CD45+ cells from 7-week-old male and female wild-type mice.
(B) Proportion of each cluster identified in scRNA-seq analysis.
(C) Heatmap showing normalized expression levels of cluster-specific genes.
(D) Violin plots showing Cx3cr1, Timd4, and Lyve1 expression by cells from clusters 1–6.
(E) Flow-cytometry plot showing Ly6C and CCR2GFP expression among adrenal gland CD45+CD11b+CD64+ cells in male and female CCR2GFP/+ mice. Data are representative of three independent experiments.
(F) Flow-cytometry plot showing Ly6C and TdTomato expression among adrenal gland CD45+CD11b+CD64+ cells from male and female CCR2creERT2 x R26TdTomato mice 48 h after TAM gavage. Data are representative of two independent experiments.
(G) Quantification of TdTomato+ macrophages in 16- to 20-week-old male and female heterozygous (CCR2+/-, ♂ n = 6 and ♀ n = 6) or double knockin (CCR2-/-, ♂ n = 4 and ♀ n = 3) CCR2creERT2 x R26TdTomato mice 48 h after TAM gavage. Data are pooled from two independent experiments.
(H) Histograms representing R26TdTomato expression in AGMs from 10-week-old female CCR2creERT2/+ x R26TdTomato mice 2, 7, and 14 days after TAM gavage. Data are representative of one (days 7 and 14) or two (day 2) experiments.
(I) Proportions of TdTomato+ macrophages from 10-week-old female CCR2creERT2/+ x R26TdTomato mice 2 (n = 8), 7 (n = 4), and 14 (n = 3) days after TAM gavage. Data from one (days 7 and 14) or two (day 2) experiments.
(J) Proportions of TdTomato+ macrophages from 8 (♂ n = 2, ♀ n = 6) or 16 (♂ n = 5, ♀ n = 5)-week-old male and female Ms4a3cre/+ x R26TdTomato mice. Data are from one experiment.
(K) Quantification of AGMs in male and female CCR2+/- (♂ n = 18, ♀ n = 21) and CCR2-/- (♂ n = 10, ♀ n = 10) mice. Data are pooled from four independent experiments.
(L) Proportions of Ki67+ AGMs in male and female CCR2+/- (♂ n = 11, ♀ n = 11) and CCR2-/- (♂ n = 6, ♀ n = 5) mice. Data are pooled from two independent experiments.
Statistical analysis was performed using two-way ANOVA with Bonferroni’s post-test.
See also Figure S2.
Figure 3Embryonic and monocyte-derived adrenal gland macrophages are distinct subsets identified through CX3CR1 expression
(A) (Left) Representative plot of macrophage CX3CR1-GFP and R26TdTomato expression and (right) proportions of CX3CR1-GFP+ and CX3CR1-GFP- cells among R26TdTomato+ AGMs from (n = 3) female CX3CR1GFP/+ CCR2CreERT2/+ R26TdTomato mice 48 h post TAM gavage. Data are from one experiment.
(B) Representative plot of macrophage CX3CR1 and R26TdTomato expression in double reporter CX3CR1creERT2/GFP R26TdTomato mice 48 h post TAM administration. Data are from one experiment.
(C) Representative plot of macrophage CX3CR1 and R26TdTomato expression in double reporter CX3CR1creERT2/GFP R26TdTomato mice 7 days post tamoxifen administration. Data are from one experiment.
(D) Flow-cytometry plot showing Timd4 and CX3CR1 expression by AGMs. Data are representative of at least 4 independent experiments.
(E) Embryonic labeling of CX3CR1creERT2 R26TdTomato mice was performed at E14.5. R26TdTomato+ cells were identified in 8-week-old male (n = 4) and female (n = 2) offspring. Data are representative of 2 independent experiments.
(F) Embryonic labeling of CX3CR1creERT2 R26TdTomato mice was performed at E18.5. R26TdTomato+ cells were identified in 10-week-old female offspring. Scale bar: 200 μm. Data are representative of 2 independent experiments.
(G) Flow-cytometry analysis of Timd4 and MHC class II expression in AGMs from E18–E20 embryos and male adult (9-week-old) mice. Data are from one experiment.
(H) Embryonic labeling of CX3CR1creERT2 R26TdTomato mice was performed at E14.5. R26TdTomato+ cells were identified in 1-week-old male offspring (left panel), which comprised mainly Tidm4+ Lyve1+ cells (right panel). Data are representative of n = 2 mice. Data are from one experiment. Two-tailed Mann-Whitney tests were used for statistical analysis.
See also Figure S3.
Figure 4MHC class IIlow macrophages are a female-specific subset with restricted localization
(A) scRNA-seq analysis of CD74, H2-Aa, Ciita, and the KEGG pathway “Antigen processing and presentation” expression among myeloid cells.
(B) (Top) Flow-cytometry plots showing F4/80 and MHC class II expression among AGMs from 7-week-old male and female mice. (Bottom) Proportions and numbers of MHC class IIhigh and class IIlow AGMs from 7-week-old male and female wild-type mice. ♂ n = 16 and ♀ n = 15. Data are pooled from 3 independent experiments.
(C) Fluorescence-microscopy analysis of CD68 and MHC class II expression in adrenal glands from 7-week-old male and female mice. Scale bar: 200 μm. M, medulla; C, cortex. Data are representative of at least 3 independent experiments.
(D) Distribution of CD68+ cells between cortex and medulla from adrenal glands of 7-week-old male and female mice. Data are represented as proportion of CD68+ cells from each zone among total cells. ♂ n = 4 and ♀ n = 6. Quantification from one experiment.
(E) Proportion of MHC-IIhigh and MHC-IIlow CD68+ cells in the cortex and medulla of adrenal glands from 7-week-old male and female mice. ♂ n = 4 and ♀ n = 6. Quantification from one experiment.
(F) Analysis of macrophage metabolic activity using SCENITH, represented by Puromycin MFI (n = 14). Data pooled from 4 independent experiments.
(G) Measure of glycolytic and mitochondrial metabolism in macrophages using SCENITH (n = 10–11). Data pooled from 3 independent experiments.
Statistical analysis was performed using two-tailed Mann-Whitney tests (panel B, quantifications), two-way ANOVA with Bonferroni’s post-test (proportions in panel B, panel D and panel E), or paired Wilcoxon t-tests (panels F and G). See also Figure S4.
Figure 5Adrenal gland macrophage sex-dimorphism is established with organ maturation and depends on X-zone presence
(A) Representative plots showing AGM MHC-II and Lyve1 expression in male 1- or 7-week-old mice. Data representative of 2 independent experiments.
(B) Proportions of MHC-IIlow Lyve1+ macrophages in male and female 1-(♂ n = 8, ♀ n = 8), 3-(♂ n = 3, ♀ n = 3) or 7 to 9-week-old (♂ n = 13, ♀ n = 13) mice. Data pooled from 2 independent experiments.
(C) Quantification of MHC-IIhigh AGMs in male and female 1- (♂ n = 9, ♀ n = 7) or 7-week-old (♂ n = 5, ♀ n = 5) mice. Data are pooled from 2 independent experiments.
(D) (Left) Representative plots showing MHC class II expression and (right) proportions of MHC class IIlow macrophages in male and female 4- (♂ n = 4, ♀ n = 3) and 5-week-old (♂ n = 7, ♀ n = 10) wild-type mice. Data are pooled from 2 independent experiments.
(E) (Left) Representative plots showing MHC class II expression and (right) proportions of MHC class IIlow AGMs in 7-week-old castrated (n = 6) and sham-operated (n = 6) wild-type male mice. Data are pooled from 2 independent experiments.
(F) Confocal-microscopy analysis of MHC class II and CD68 expression in 7-week-old castrated and sham-operated wild-type mice. The X-zone is comprised between white and orange dots. Scale bar: 200 μm. M, medulla; C, cortex; ZX, X- zone. Data are representative of 2 independent experiments.
(G) (Left) Representative plots showing MHC class II expression and (right) proportions of MHC class IIlow AGMs in female retired breeders (n = 7) and age-matched nulliparous (n = 6) mice. Data are pooled from 2 independent experiments.
(H) Fluorescence-microscopy analysis of CD68 and MHC class II expression in adrenal glands from 12-week-old female retired breeders and age-matched nulliparous mice. The X zone is comprised between white and orange dots. Scale bar: 100 μm. M, medulla; C, cortex. Data are representative of 2 independent experiments.
(I) Proportions of MHC class IIlow macrophages in female mice treated with anti-IL-10R-blocking antibody or isotype control. Data are pooled from 3 independent experiments.
Statistical analysis was performed using two-way ANOVA with Bonferroni’s post-test (B–D) or two-tailed Mann-Whitney tests (E, G, and I).
See also Figure S5.
Figure 6Adrenal gland macrophages control tissue lipid metabolism
(A) (Left) Representative plots and (right) quantification of AGMs in 7- to 8-week-old CX3CR1GFP/+ mice after macrophage depletion using α-CD115 (n = 5) or isotype control (n = 5).
(B) Microscopy analysis of adrenal glands from α-CD115- or isotype-control-treated CX3CR1GFP/+ mice. One microscopy experiment was performed to confirm depletion efficiency.
(C) Microscopy analysis of adrenal glands from α-CD115- or isotype-control-treated male mice using Bodipy staining. Data are from one experiment.
(D) Quantification of Bodipy+ particles of different sizes in adrenal glands from α-CD115- (n = 3) or isotype-control- (n = 3) treated male mice. Data are from one experiment.
(E) Aldosterone and corticosterone levels in adrenal gland homogenates from 8-week-old α-CD115- (n = 5) or isotype-control- (n = 5) treated female mice submitted to a 12 h cold challenge. Data are from one experiment.
(F) Quantification of Bodipy+ particles of different sizes in adrenal glands from 8-week-old α-CD115- (n = 5) or isotype-control- (n = 5) treated female mice submitted to a 12 h cold challenge.
Statistical analysis was performed using two-way ANOVA with Bonferroni’s post-test (D and F) or two-tailed Mann-Whitney tests (A and E).
See also Figure S6.
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| CD11b PE-Cy5 (Clone M1/70) | Biolegend | Cat# 101209, RRID: |
| CD11b Brilliant Violet 510 (Clone M1/70) | Biolegend | Cat# 101263, RRID: |
| CD11b APC-Cy7 (Clone M1/70) | Biolegend | Cat# 101226, RRID: |
| F4/80 PE-Cy7 (Clone BM8) | Biolegend | Cat# 123114, RRID: |
| F4/80 Alexa Fluor 488 (Clone BM8) | Biolegend | Cat# 123120, RRID: |
| F4/80 Brilliant Violet 650 (Clone BM8) | Biolegend | Cat# 123149, RRID: |
| F4/80 APC (Clone REA126) | Miltenyi | Cat# 130-116-525 RRID: |
| CD45 APC-Cy7 (Clone 30-F11) | BD Biosciences | Cat# 557659, RRID: |
| CD45 Pacific Blue (Clone 30-F11) | Biolegend | Cat# 103126, RRID: |
| CD45 VioGreen (Clone REA737) | Miltenyi | Cat# 130-110-803, RRID: |
| CD45 Brilliant Violet 570 (Clone 30-F11) | Biolegend | Cat# 103136, RRID: |
| CD45 APC-Vio 770 (Clone REA737) | Miltenyi | Cat# 130-110-662, RRID: |
| CD64 Brillant Violet 421 (Clone ×54-5/7.1) | Biolegend | Cat# 139309, RRID: |
| CD64 Brillant Violet 711 (Clone ×54-5/7.1) | Biolegend | Cat# 139311, RRID: |
| CD64 PE/Dazzle 594 (Clone ×54-5/7.1) | Biolegend | Cat# 139320, RRID: |
| Ly6C APC (Clone HK1.4) | Biolegend | Cat# 128015, RRID: |
| Ly6C PerCP-Cy5.5 (Clone HK1.4) | Biolegend | Cat# 128012, RRID: |
| Ly6G PerCP-Cy5.5 (Clone 1A8) | Biolegend | Cat# 127615, RRID: |
| Ly6G Brilliant Violet 510 (Clone 1A8) | Biolegend | Cat#127633, RRID: |
| Ly6G Brilliant Violet 785 (Clone 1A8) | Biolegend | Cat# 127645, RRID: |
| Klrg1 PE-Cy7 (Clone 2F1/KLRG1) | Biolegend | Cat# 138416, RRID: |
| CD115 PE-Cy7 (AFS98) | Biolegend | Cat# 135524, RRID: |
| CD115 PE (Clone AFS98) | Biolegend | Cat# 135506, RRID: |
| CD115 PE (Clone REA827) | Miltenyi | Cat# 130-112-639, RRID: |
| Gr-1 PerCP-Cy5.5 (Clone RB6-8C5) | Biolegend | Cat# 108426, RRID: |
| NK1.1 FITC (Clone PK136) | Biolegend | Cat# 108706, RRID: |
| Sca1 Pacific Blue (Clone D7) | Biolegend | Cat# 108120, RRID: |
| CD19 PE (Clone REA749) | Miltenyi | Cat# 130-112-035, RRID: |
| CD19 BUV737 (Clone 1D3) | BD Biosciences | Cat# 612782, RRID: |
| CD3 APC (Clone 17A2) | Biolegend | Cat# 100236, RRID: |
| CD8a Brilliant Violet 510 (Clone 53-6.7) | Biolegend | Cat# 100752, RRID: |
| CD4 Alexa Fluor 700 (Clone RM4-5) | Biolegend | Cat# 100536, RRID: |
| MHC-II IA/IE PE (Clone 2G9) | BD Biosciences | Cat# 558593, RRID: |
| MHC-II IA/IE FITC (Clone 2G9) | BD Biosciences | Cat# 553623, RRID: |
| MHC-II IA/IE Brilliant Violet 510 (Clone M5/114.15.2) | Biolegend | Cat# 107636, RRID : AB_2734168 |
| MHC-II IA/IE Alexa Fluor 647 (Clone M5/114.15.2) | Biolegend | Cat# 107618, RRID: |
| MHC-II VioBlue (Clone REA813) | Miltenyi | Cat# 130-112-394, RRID: |
| Timd4 PE-Cy7 (Clone RMT4-54) | Biolegend | Cat# 130010, RRID: |
| Timd4 PerCP-eFluor710 (Clone RMT4-54) | Invitrogen | Cat# 46-5866-80, RRID: |
| Lyve1 eFluor660 (Clone ALY7) | Invitrogen | Cat# 50-0443-80, RRID: |
| CD206 PerCP-Cy5.5 (Clone C068C2) | Biolegend | Cat# 141716, RRID: |
| MerTK PE (Clone 2B10C42) | Biolegend | Cat# 151506, RRID: |
| MerTK APC (Clone 2B10C42) | Biolegend | Cat# 151508, RRID: |
| CD11c PE-Cy7 (Clone HL3) | BD Biosciences | Cat# 558079, RRID: |
| CD24 BUV496 (Clone M1/69) | BD Biosciences | Cat# 612953, RRID: |
| NKp46 Brilliant Violet 421 (Clone 29A1.4) | Biolegend | Cat# 137611, RRID: |
| CCR2 APC-Fire750 (Clone SA203T11) | Biolegend | Cat# 150629, RRID :AB_2810416 |
| CD40 BUV395 (Clone 3/23) | BD Biosciences | Cat# 745697, RRID: |
| CD40 APC-Vio770 (Clone REA965) | Miltenyi | Cat# 130-116-113, RRID: |
| CD80 BUV615 (Clone 16-10A1) | BD Biosciences | Cat# 751328, RRID: |
| CD80 PerCP-Vio770 (Clone REA983) | Miltenyi | Cat# 130-116-464, RRID: |
| CD86 BUV805 (Clone GL1) | BD Biosciences | Cat# 741946, RRID: |
| CD86 PE (Clone REA1190) | Miltenyi | Cat# 130-122-129, RRID: |
| ICOSL (CD275) PE-Vio770 (Clone REA990) | Miltenyi | Cat# 130-116-448, RRID: |
| CD68 Alexa Fluor 647 (Clone FA-11) | Biolegend | Cat# 137004, RRID: |
| BioXCell | Cat# BE0213, RRID: | |
| BioXCell | Cat# BE0089, RRID: | |
| BioXCell | Cat# BE0050, RRID: | |
| InVivoMAb anti-mouse CD16/CD32 (Clone 2.4G2) | BioXCell | Cat# BE0307, RRID: |
| DAPI | Sigma | Cat# D9542 |
| LIVE/DEAD™ Fixable Violet Dead Cell Stain Kit | ThermoFisher | Cat# L34955 |
| PFA 4% | VWR International | Cat# 9713.1000 |
| Bovine serum Albumin (BSA) | Sigma | Cat# A7030 |
| Tamoxifen | Sigma | Cat# T5648 |
| Collagenase A | Sigma | Cat# 11088793001 |
| IHC Antigen retrieval solution | eBiosciences | Cat# 00-4955-58 |
| Antifade mounting medium with DAPI | Vectashield | Cat# H-1500 |
| Fetal bovine serum | Fisher Scientific | Cat# 12350273 |
| Lysing buffer | BD Biosciences | Cat# 555899 |
| Liberase | Roche | Cat# 05401054001 |
| DNAse I | Roche | Cat# 10104159001 |
| Penicillin Streptomycin | Life Technologies | Cat# 15070063 |
| L-Glutamine | Life Technologies | Cat# 25030024 |
| Mouse M-CSF | Miltenyi Biotec | Cat# 130-094-129 |
| RPMI medium | Life Technologies | Cat# 21875091 |
| Clorgyline | Abcam | Cat# ab145646 |
| Norepinephrine | Sigma | Cat# A7257 |
| TRITC-Dextran 65–85 kDa | Sigma | Cat# T1162 |
| Bodipy | Thermofisher | Cat# D3922 |
| Mouse CCL2 DuoSet ELISA | R&D Systems | Cat# DY479-05 |
| Norepinephrine ELISA Kit | Tebu-bio | Cat# 157KA1891 |
| Aldosterone Parameter Assay Kit | R&D Systems | Cat# KGE016 |
| Corticosterone Parameter Assay Kit | R&D Systems | Cat# KGE009 |
| Ki67 Staining Kit PE | BD Biosciences | Cat# 51-36525× |
| FoxP3 Staining Buffer Set | Miltenyi | Cat# 130-093-142 |
| RNA extraction kit | QIAGEN | Cat# 74136 |
| Prism 8 | GraphPad | N/A |
| Chromeleon software | Thermo Scientific | N/A |
| FlowJo | Tree Star | N/A |
| Seurat package version 3.1.0 | N/A | |
| BD FACSDiva | BD Biosciences | N/A |
| ImageJ | NIH | N/A |
| SpectroFlo | Cytek | N/A |
| Phantasus | Artyomov Lab | N/A |